{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:39Z","timestamp":1787021319087,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1245\/s10434-026-19131-0","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T18:19:03Z","timestamp":1771438743000},"page":"4563-4572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Second Ipsilateral Breast Cancer Event: True Recurrence, New Primary, or True Recurrence Like?"],"prefix":"10.1245","volume":"33","author":[{"given":"Nina","family":"Pujol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Courtault-Deslandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Schiappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Hannoun-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"19131_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin."},{"key":"19131_CR2","doi-asserted-by":"publisher","first-page":"109698","DOI":"10.1016\/j.radonc.2023.109698","volume":"185","author":"O Kaidar-Person","year":"2023","unstructured":"Kaidar-Person O, Giasafaki P, Boersma L, De Brouwer P, Weltens C, Kirkove C, EORTC Radiation Oncology and Breast Cancer Groups, et al. Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: results from EORTC 22922\/10925. J Radiother Oncol. 2023;185:109698.","journal-title":"J Radiother Oncol."},{"key":"19131_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1200\/JCO.1984.2.1.37","volume":"2","author":"JR Harris","year":"1984","unstructured":"Harris JR, Recht A, Amalric R, Calle R, Clark RM, Reid JG, et al. Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer. J Clin Oncol. 1984;2:37\u201341. https:\/\/doi.org\/10.1200\/JCO.1984.2.1.37.","journal-title":"J Clin Oncol."},{"key":"19131_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ijrobp.2020.12.029","volume":"110","author":"JM Hannoun-Levi","year":"2021","unstructured":"Hannoun-Levi JM, Gal J, Van Limbergen E, Chand ME, Schiappa R, Smanyko V, et al. Salvage mastectomy versus second conservative treatment for second ipsilateral breast tumor event: a propensity score-matched cohort analysis of the GEC-ESTRO Breast Cancer Working Group database. Int J Radiat Oncol Biol Phys. 2021;110:452\u201361. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.029.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"19131_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320.PMID:31750868;PMCID:PMC6902101","volume":"6","author":"DW Arthur","year":"2020","unstructured":"Arthur DW, Winter KA, Kuerer HM, Haffty B, Cuttino L, Todor DA, et al. Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: the NRG Oncology\/RTOG 1014 phase 2 clinical trial. JAMA Oncol. 2020;6:75\u201382. https:\/\/doi.org\/10.1001\/jamaoncol.2019.4320.PMID:31750868;PMCID:PMC6902101.","journal-title":"JAMA Oncol."},{"key":"19131_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110659","volume":"203","author":"JM Hannoun-Levi","year":"2025","unstructured":"Hannoun-Levi JM, Savignoni A, Lemonnier J, Kirova Y. Randomized trials: when scientific rigor meets field reality. Radiother Oncol. 2025;203:110659. https:\/\/doi.org\/10.1016\/j.radonc.2024.110659.","journal-title":"Radiother Oncol."},{"key":"19131_CR7","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1200\/JCO.2008.19.8424","volume":"27","author":"SJ Anderson","year":"2009","unstructured":"Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27:2466\u201373. https:\/\/doi.org\/10.1200\/JCO.2008.19.8424.","journal-title":"J Clin Oncol."},{"key":"19131_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0360-3016(98)90002-5","volume":"15","author":"A Recht","year":"1988","unstructured":"Recht A, Silen W, Schnitt SJ, Connolly JL, Gelman RS, Rose MA, et al. Time-course of local recurrence following conservative surgery and radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 1988;15:255\u201361. https:\/\/doi.org\/10.1016\/s0360-3016(98)90002-5.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"19131_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnci\/87.1.19","volume":"87","author":"U Veronesi","year":"1995","unstructured":"Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;87:19\u201327. https:\/\/doi.org\/10.1093\/jnci\/87.1.19.","journal-title":"J Natl Cancer Inst."},{"key":"19131_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0360-3016(00)01378-X","volume":"48","author":"TE Smith","year":"2000","unstructured":"Smith TE, Lee D, Turner BC, Carter D, Haffty BG. True recurrence vs new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000;48:1281\u20139.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"19131_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.ijrobp.2023.06.075","volume":"117","author":"JM Hannoun-Levi","year":"2023","unstructured":"Hannoun-Levi JM, Gal J, Polgar C, Strnad V, Loessl K, Polat B, et al. Second conservative treatment for local recurrence breast cancer: a GEC-ESTRO oncological outcome and prognostic factor analysis. Int J Radiat Oncol Biol Phys. 2023;117:1200\u201310. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.06.075.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"19131_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ctro.2022.10.008","volume":"38","author":"JM Hannoun-Levi","year":"2022","unstructured":"Hannoun-Levi JM, Gal J, Schiappa R, Chand ME. 10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event. Clin Transl Radiat Oncol. 2022;38:71\u20136. https:\/\/doi.org\/10.1016\/j.ctro.2022.10.008.","journal-title":"Clin Transl Radiat Oncol."},{"key":"19131_CR13","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/cncr.10952","volume":"95","author":"E Huang","year":"2002","unstructured":"Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 2002;95:2059\u201367.","journal-title":"Cancer."},{"key":"19131_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ijrobp.2004.04.010","volume":"60","author":"DJ Krauss","year":"2004","unstructured":"Krauss DJ, Kestin LL, Mitchell C, Martinez AA, Vicini FA. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys. 2004;60:731\u201340.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"19131_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2325\/jbcs.12.104","volume":"12","author":"Y Komoike","year":"2005","unstructured":"Komoike Y, Akiyama F, Iino Y, Ikeda T, Tanaka-Akashi S, Ohsumi S, et al. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer. 2005;12:104\u201311.","journal-title":"Breast Cancer."},{"key":"19131_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2325\/jbcs.12.112","volume":"12","author":"S Nishimura","year":"2005","unstructured":"Nishimura S, Takahashi K, Akiyama F, Oguchi M, Tada K, Makita M, et al. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis. Breast Cancer. 2005;12:112\u20137.","journal-title":"Breast Cancer."},{"key":"19131_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1524-4741.2009.00884.x","volume":"16","author":"T Yoshida","year":"2010","unstructured":"Yoshida T, Takei H, Kurosumi M, Ninomiya J, Ishikawa Y, Hayashi Y, et al. True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment. Breast J. 2010;16:127\u201333.","journal-title":"Breast J."},{"key":"19131_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ijrobp.2010.05.063","volume":"81","author":"V Panet-Raymond","year":"2011","unstructured":"Panet-Raymond V, Truong PT, McDonald RE, Alexander C, Ross L, Ryhorchuk A, Watson PH. True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2011;81:409\u201317.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"19131_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/SLA.0b013e318208fc2a","volume":"253","author":"M Yi","year":"2011","unstructured":"Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, et al. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg. 2011;253:572\u20139.","journal-title":"Ann Surg."},{"key":"19131_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/pin.12253","volume":"65","author":"T Sakai","year":"2015","unstructured":"Sakai T, Nishimura S, Ogiya A, Tanabe M, Kimura K, Morizono H, et al. Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination. Pathol Int. 2015;65:113\u20138.","journal-title":"Pathol Int."},{"key":"19131_CR21","first-page":"1001","volume":"20","author":"E Alexandrova","year":"2015","unstructured":"Alexandrova E, Sergieva S, Kostova P, Mihaylova I, Katzarov D, Milev A. Ipsilateral in-breast tumor recurrence after breast-conserving therapy: true recurrence versus new primary tumor. J BUON. 2015;20:1001\u20138.","journal-title":"J BUON."},{"key":"19131_CR22","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.ejso.2021.06.013","volume":"47","author":"J Wang","year":"2021","unstructured":"Wang J, Tang H, Yin K, Li X, Xie X, Hughes KS. Second invasive breast cancers in patients treated with breast-conserving therapy. Eur J Surg Oncol. 2021;47:2492\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"19131_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-022-06680-7","volume":"195","author":"JJ Jobsen","year":"2022","unstructured":"Jobsen JJ, Struikmans H, Siemerink E, van der Palen J, Heijmans HJ. The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary. Breast Cancer Res Treat. 2022;195:249\u201362.","journal-title":"Breast Cancer Res Treat."},{"key":"19131_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejca.2021.10.008","volume":"159","author":"JM Hannoun-Levi","year":"2021","unstructured":"Hannoun-Levi JM, Gutierrez C, Polgar C, Strnad V, BCWG of the GEC-ESTRO. Letter comments on: the impact of isolated local recurrence on long-term outcome in early breast cancer patients after breast-conserving therapy. Eur J Cancer. 2021;159:224\u20136. https:\/\/doi.org\/10.1016\/j.ejca.2021.10.008.","journal-title":"Eur J Cancer."},{"key":"19131_CR25","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1158\/1078-0432.CCR-22-2883","volume":"29","author":"E Rassy","year":"2023","unstructured":"Rassy E, Garberis I, Tran-Dien A, Job B, Chung-Scott V, Bouakka I, et al. Comparative genomic profiling of second breast cancers following first ipsilateral hormone receptor-positive breast cancers. Clin Cancer Res. 2023;29:1822\u201331. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-2883.","journal-title":"Clin Cancer Res."},{"key":"19131_CR26","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1200\/JCO.2017.76.5719","volume":"36","author":"IL Wapnir","year":"2018","unstructured":"Wapnir IL, Price KN, Anderson SJ, Robidoux A, Mart\u00edn M, Nortier JWR, International Breast Cancer Study Group; NRG Oncology, GEICAM Spanish Breast Cancer Group, BOOG Dutch Breast Cancer Trialists\u2019 Group; Breast International Group, et al. Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial. J Clin Oncol. 2018;36:1073\u20139. https:\/\/doi.org\/10.1200\/JCO.2017.76.5719.","journal-title":"J Clin Oncol."},{"key":"19131_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10549-022-06570-y","volume":"193","author":"H Nakagomi","year":"2022","unstructured":"Nakagomi H, Inoue M, Hirotsu Y, Amemiya K, Mochiduki H, Omata M. PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery. Breast Cancer Res Treat. 2022;193:349\u201359.","journal-title":"Breast Cancer Res Treat."},{"key":"19131_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002351","author":"M Fern\u00e1ndez-Abad","year":"2025","unstructured":"Fern\u00e1ndez-Abad M, Caniego-Casas T, Carretero-Barrio I, Calderay-Dom\u00ednguez M, Saavedra C, Hardisson D, et al. Ipsilateral breast carcinoma recurrence: true recurrence or new primary? A clinicopathologic and molecular study. Am J Surg Pathol. 2025. https:\/\/doi.org\/10.1097\/PAS.0000000000002351.","journal-title":"Am J Surg Pathol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19131-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:25:58Z","timestamp":1776255958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19131-0"}},"subtitle":["Breast Cancer Local Recurrence"],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["19131"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19131-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}